Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
Published Online: 2019-05-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: A Anthoney•A Bateman•AA Mukhtar•Alan Anthony•B Davidson•Brian Davidson•C Archer•C Iwuji•C Rees•C Stubbs•Clive Stubbs•D Adamson•D Cunningham•D Mirza•D Palmer•D Stocken•D Tsang•Daniel H Palmer•Darius Mirza•David Cunningham•Deborah Stocken•E Beaumont•F Coxon•G Cogill•H Malik•H Morement•H Wasan•Harpreet Wasan•Hassan Z Malik•I Pope•J Bridgewater•J Dent•J Evans•J Garden•J Neoptolemos•J Raftery•J Wadsley•J Waters•JG Thorpe•JN Primrose•JW Valle•James Raftery•Jeff T R Evans•John Bridgewater•John N Primrose•John P Neoptolemos•Jonathan Wadsley•Juan W Valle•K Sharkland•K Sumpter•L Nolan•L Wall•Lucy Wall•M Finch-Jones•M Peterson•Meg Finch-Jones•O Chan•O Faluyi•O James Garden•P Corrie•P Ross•Paul Ross•Pippa Corrie•R Gillmore•R Prasad•R Praseedom•RP Fox•Raaj Praseedom•Raj Prasad•Richard P Fox•S Cummins•S Darby•S Falk•S Maduhusudan•S Slater•S Sothi•S Zhu•Shihua Zhu•Stephen Falk•T Crosby•T Hickish•T Iveson•Tim Iveson•U Dernedde•U Hombaiah•YT Ma•Yuk Ting Ma
